Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-19FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s original application for lurasidone hydrochloride (generic lurasidone).
-
FDA approval · 2019-03-08FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, a long-acting antipsychotic.
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch [Phase 4]
Phase 4 clinical trial evaluating the effects of long-acting injectable aripiprazole on psychosocial/cognitive functioning and patient-repor…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy [Phase 4]
Phase 4 clinical trial comparing propofol target-controlled infusion anesthesia with bolus injection for electroconvulsive therapy in adults…
-
FDA approval · 2019-03-01FDA Approved: PERPHENAZINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original ANDA for PERPHENAZINE from Rising Pharma Holdings, Inc., making a generic version of the antipsychotic available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial [NA]
This update reports on a pilot clustered randomized controlled trial evaluating the potential efficacy of the Chinese Health Improvement Pro…
-
FDA approval · 2019-02-21FDA Approved: ARIPIPRAZOLE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic version of aripiprazole.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics [Phase 1]
Phase 1 clinical trial assessing early predictors of poor treatment response in schizophrenia patients treated with atypical antipsychotics.…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study [NA]
This update reports the completion of a feasibility trial of Mindfulness-based Social Cognition Training (SocialMind) for schizophrenia and …
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia [Phase 1]
Pfizer completed a Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of PF-06412562 in adults with schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Person-Centered Versus Measurement-Based Care in Mental Health [NA]
Completed clinical trial comparing person-centered care to measurement-based care in mental health; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Waist Circumference Measurements in Schizophrenic Patients
A completed clinical trial assessing waist circumference measurements in patients with schizophrenia has been reported.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia [Phase 2]
A Phase 2 double-blind trial evaluating adjunctive valacyclovir to improve cognition in early-phase schizophrenia has completed. Results hav…
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique
A completed clinical trial from the University of Barcelona explored how personal identity relates to psychotic symptoms using the Repertory…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: rTMS in First Episode Psychosis [NA]
Clinical trial update for rTMS in first-episode psychosis has completed; results posted in 2019.
-
FDA label_change · 2019-01-25FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA supplemental application for Risperdal M-TAB (risperidone) by Janssen Pharmaceuticals, involving changes to the product label. This acti…
-
FDA approval · 2019-01-25FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2019-01-25FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approves a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, pertaining to the existin…
-
FDA approval · 2019-01-25FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved a supplemental application for INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]
Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed …
-
FDA approval · 2019-01-25FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., indicating a supplemental app…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
The FIRST trial, evaluating a family-based psychosocial intervention for recent-onset schizophrenia, has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Clinical Trial of AVL-3288 in Schizophrenia Patients [Phase 1]
A Phase 1 clinical trial of AVL-3288 in patients with schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Glutamate, Brain Connectivity and Duration of Untreated Psychosis
This update reports the completion of a clinical trial examining glutamate-related brain connectivity and the duration of untreated psychosi…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Examining Persistence in Smokers With Schizophrenia [NA]
Clinical trial update for a completed Rutgers study examining persistence in smokers with schizophrenia, focusing on smoking cessation in th…